维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="Bhalla KN"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies显示文摘	Bhalla KN	2005	Clin Oncol2005，23，17：	1
2	The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy 显示文摘	Blagosklonny MV Fojo T Bhalla KN	2001	Leukemia2001，15，：	1
3	Nilotinib in chronic myeloid leukemia patients in chronic phase (CMLCP) with imatinib resistance or intolerance : 2-year follow-up results of a phase 2 study显示文摘	KANTARJIAN HM GILES F BHALLA KN	2008	Blood ( ASH Annual Meeting Abstracts)2008，112，：	1
4	Microtubule-targeted anticancer agents and apoptosis显示文摘	Bhalla KN	2003	Oncogene2003，22，56：	1
5	The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy 显示文摘	Blagosklonny MV Fojo T Bhalla KN	2001	Leukemia2001，15，：	1
6	Microtubule-targated anticancer agents and apoptosis显示文摘	BHALLA KN	2003	Oncogene2003，22，56：	1
7	The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Ahl- expressing leukemia cells to cytotoxic chemotherapy 显示文摘	Blagosklonny MV Fojo T Bhalla KN	2001	Leukemia2001，15，10：	1
8	Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies显示文摘	Bhalla KN	2005	J Clin Oncol2005，23，17：	1
9	Microtubule-targeted anticancer agents andapoptosis显示文摘	Bhalla KN	2003	Oncogene2003，22，56：	1
10	Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies 显示文摘	Bhalla KN	2005	Clin Oncol2005，23，17：	1
11	First - in - human phase I dose - escalation study of the Hsp90 inhibitor AUY922 in patients with advanced solid tumors 显示文摘	Sessa C Shapiro GI Bhalla KN	2013	Clini- cal Cancer Research2013，19，13：	1
12	Asenic induce apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-xL 显示文摘	Caryn NK Goufu F Perkins C Kim CN Fang G Bhalla KN	2002	Blood2002，95，3：	1
13	Microtubule-targeted anticancer agents and apoptosis显示文摘	Bhalla KN	2003	Oncogene2003，22，56：	1
14	Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies 显示文摘	Bhalla KN	2005	J Clin Oncol2005，23，17：	1
15	Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies显示文摘	Bhalla KN	2005	J Clin Oncol2005，23，：	1
16	Potent Inhibition of Platelet-Derived Growth Factor-Induced Responses in Vascular Smooth Muscle Cells by BMS-354825 (Dasatinib) 显示文摘	( hen Z Lee FY Bhalla KN	2006	Mol Pharmaco12006，69，5：	1
17	Microtubule-targeted anticancer agents and apoptosis显示文摘	Bhalla KN	2003	Oncogene2003，22，56：	1
18	The role of Apaf-1,caspase-9,and bid proteins in etoposide-or paclitaxel-induced mitochondrial events during apoptosis显示文摘	Perkins CL Fang G Kim CN Bhalla KN	2000	Cancer Res2000，60，6：	1
19	Microtubule-targeted anticancer agents andapoptosis显示文摘	Bhalla KN	2003	Oncogene2003，22，56：	1
20	First-in-human phase I dose-escalation study of the HSP90 inhibitor AUY922 in patients with advanced solid tumors 显示文摘	Sessa C Shapiro GI Bhalla KN	2013	Clin Cancer Res2013，19，13：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示